# Center for Advanced Reproductive Endocrinology – FDA Inspection, Nov 13, 2018

Source: https://www.keypedia.com/records/fda_inspections/center-for-advanced-reproductive-endocrinology/cf8d4260-921d-45b2-81b5-6c583cab9384
Source feed: FDA_Inspections

> FDA inspection 1071477 of Center for Advanced Reproductive Endocrinology, November 13, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 1271. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1071477
- Company Name: Center for Advanced Reproductive Endocrinology
- Inspection Date: 2018-11-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 888838 - 2014-07-25](https://www.keypedia.com/records/fda_inspections/center-for-advanced-reproductive-endocrinology/e8f4fde6-d117-4cbb-a236-24bc92d5a95e)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/ivan-e-reyes/69bac3eb-f63c-45f0-8420-85a7e06b884a)

Company: https://www.keypedia.com/companies/center-for-advanced-reproductive-endocrinology/f81f352e-6e3a-41e6-a8f4-9c6b1ec4d2eb

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d